Advertisement

Staff Editors

PLOS is a tax-exempt, 501(c)3, nonprofit corporation. PLOS' overall revenues and funding information are listed in the PLOS Annual Update.

The PLOS Medicine editors are paid a fixed salary (in particular, their salary is not linked to the number of papers published in the journal). Editors are required to declare all relevant competing interests and do not participate in the review of any paper for which they have a competing interest.

The competing interests statements in the boxes below were updated in February 2017, and relate to activities over the previous 12 months. However, relevant competing interests from previous years will also be taken into account when deciding whether it is appropriate for an editor to handle a paper.

Larry Peiperl

Chief Editor
0000-0003-1237-4846

A Board Certified Internist, Larry has taught and practiced primary care for many years in clinics serving low-income patients in San Francisco and New York City. His background in clinical research includes leadership of NIH-sponsored HIV vaccine and treatment trial protocol teams. He rejoined PLOS Medicine in 2013 as Chief Editor after 3 years as a Clinical Professor at the University of California San Francisco (UCSF) School of Medicine. He was a research editor with PLOS Medicine from 2006 to 2010. Previously he was founding Director of UCSF’s Center for HIV Information, as well as the Editor of the HIV InSite Knowledge Base. Larry gained his undergraduate degree from Princeton University, a Master of Science degree from Stanford University, and his medical degree from UCSF. He completed residency training at UCSF and San Francisco General Hospital. He writes and serves as an invited speaker on the topic of open access to medical research, represents PLOS Medicine on the International Committee of Medical Journal Editors (ICMJE), and has provided consultation to the World Health Organization on issues related to data sharing.

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium.

I attended the World Health Organization Consultation on Data and Results Sharing during Public Health Emergencies (Geneva, September 1-2, 2015). I also attended the WHO Consultation on Zika Research and Development (Geneva, March 7-9, 2016). WHO invited me and covered my travel expenses.

I attended the Core Outcome Set-STAndards for Reporting (COS-STAR) guideline consensus meeting (London, January 28, 2016). The organizing research program at the University of Liverpool covered my travel expenses.

I received reimbursement of travel expenses from the Association of Healthcare Journalists for speaking at their Fellowship on Comparative Effectiveness Research on September 14, 2016 in Washington, D.C. 

I received reimbursement of travel expenses from the Patient Centered Outcomes Research Institute for speaking at a “Meet the Journal Editors” session at the PCORI Annual Meeting on November 18, 2016 in National Harbor, Maryland. 

  • Accommodation and travel. See above.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No.
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

None.

Stocks or shares

I hold several employment-related retirement accounts including a variety of mutual funds. I do not determine or keep track of the individual companies in which they invest.

Other competing interests

From September 2013 until June 2016, I held a volunteer faculty appointment in the Division of General Internal Medicine, San Francisco General Hospital, UCSF Department of Medicine.

Paul Simpson

Deputy Editor
0000-0002-5069-8588

Paul joined PLOS Medicine in 2011 after working as a researcher for several years at the Medical Research Council’s Laboratory of Molecular Biology (MRC-LMB) at the University of Cambridge. Prior to working at the MRC-LMB, Paul completed a PhD at the University of Birmingham, UK and a Bachelor of Science degree at the University of York, UK. He initially joined PLOS Medicine as an Editorial Intern and has worked on many aspects of the journal, handling research manuscripts, magazine pieces and, until 2014, running the Speaking of Medicine blog. 

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium. No.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No.
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

No.

Stocks or shares

  • I have contributed to the USS pension scheme. I have neither specific information nor influence about which companies the fund invests money into. My bank accounts and mortgage are with UK high street banks.
  • My wife and I have a £500 share in the Horningsea Community Interest Company. The community interest company was set up with the explicit aim of ensuring that a small village public house and restaurant “The Plough & Fleece” was run by and for the community.

Other competing interests

  • From 2003-2006 I held an Medical Research Council funded PhD studentship.
  • From 2007-2011 my salary was funded by the Leukemia & Lymphoma Society of America.

Amy Ross

Senior Editor
0000-0002-5835-7809

Amy Ross joined the PLOS Medicine team in September 2012 with a research background in clinical neuroscience, including neurological disorders, mental health, and chronic pain. She completed a PhD in Psychiatry from the University of New South Wales, where she focused on using neuroimaging biomarkers to predict cognitive impairment after stroke. This was followed by a postdoctoral research position at Mclean Hospital with Harvard Medical School, focusing on clinical research studies that investigated novel treatments and the underlying pathophysiology of psychiatric and substance use disorders. From 2007 to 2012, she worked as a Research Scientist at Omneuron, a biotechnology company in Menlo Park, developing and testing non-pharmacological treatments for chronic pain, depression, and substance use disorders using real-time functional MRI biofeedback. 

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium. No.
  • Accommodation and travel. My partner has received travel and accommodation reimbursement from BioClinica for projects related to his work.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No.
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

My partner is employed at BioClinica, a contract research organization.

Stocks or shares

My partner and I both hold mutual fund and retirement fund investments in the USA, but have no specific information or influence about which companies the funds invests their money. I also have retirement fund investments in New Zealand and Australia, but have no specific information or influence about which companies these funds invest their money.

Other competing interests

  • I personally know authors who might submit research to PLOS Medicine.
  • I have donated money to the SF Family Dog Rescue.

Clare Stone

Senior Research Editor
0000-0002-2909-7876

Clare joined PLOS Medicine in February 2015, after spending the previous seven years at BioMed Central, where she was the Editor of the flagship journal Genome Biology. Clare got her PhD in Genetics from Queen Mary College, University of London and moved to her first editorial position at Nature Publishing Group, after completing postdoctoral fellowships at the Medical Research Council’s Laboratory of Molecular Biology (MRC-LMB) and the Department of Anatomy at the University of Cambridge. At PLOS Medicine, Clare handles many of the papers that are in the area of cancer or translational medicine. She finds that open access and transparency in medical and clinical studies is of key importance to advancing clinical care and innovation. 

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium. No.
  • Accommodation and travel. No.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No.
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

No.

Stocks or shares

I have contributed to the USS pension scheme. I have neither specific information nor influence about which companies the fund invests money into. My banks accounts are with UK high street banks.

Other competing interests

From September 2005 to November 2010, I was employed by BioMed Central, a commercial open access publishing company.

Richard Turner

Senior Editor
0000-0001-9692-4360

Dr. Richard Turner, PhD, joined PLOS in the role of Senior Editor at PLOS Medicine in January 2016. With a research background in molecular biology, Richard joins us with nearly 20 years of editorial experience, most recently at The Lancet and previously, at Nature and Nature Structural & Molecular Biology. Richard’s substantial experience in editing medical research and magazine content across a broad range of topics will greatly benefit our efforts to expand the profile of PLOS Medicine in the clinical sciences. Richard’s geographical background is also well suited to PLOS. As a citizen of the UK with a doctoral degree from the University of Cambridge, he completed a postdoctoral fellowship at the University of California Berkeley and has done editorial work out of San Francisco in the past. Richard writes for the journal, commissions and handles opinion pieces, and carries out peer review of research articles. 

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium. No.
  • Accommodation and travel. No.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No.
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

My wife teaches pathology at the University of Cambridge, UK.

Stocks or shares

My retirement provision includes a small investment in mutual funds which invest in health-care businesses, but I do not monitor or influence the individual investments.

Other competing interests

No.

Colleen Crangle

Associate Editor

Colleen joined PLOS Medicine in November 2016 on short-term assignment as an Associate Editor. Her research career has spanned over 20 years in biomedical applications of computer science. Most recently she has investigated the role of machine-learning and natural-language technologies in interventions for diabetes and mental health and computational approaches to the identification of emotional states from bio-behavioral data. Colleen holds a PhD degree from Stanford University and a Master’s degree in Computer Science from the University of South Africa. 

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • I receive honoraria for service as peer reviewer for the US National Institutes of Health.
  • I have an ownership interest in Converspeech LLC, which is the recipient of funding from the National Library of Medicine (2015-2017).

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

No.

Stocks or shares

I hold retirement accounts that include a variety of mutual funds. I do not determine or keep track of the individual companies in which they invest. I also hold stock in Randgold Resources Ltd. and Netflix Inc.

Other competing interests

  • From 2003 to 2013 I held grants from the NIH National Cancer Institute, National Human Genome Research Institute, and National Library of Medicine.
  • I personally know authors who might submit research to PLOS Medicine.
  • I donate money to the Humane Society of the United States and the Human Rights Campaign.
  • From September 2006 until December 2015, I was an affiliated research scientist with the Center for the Study of Language and Information at Stanford University and was funded by the Patrick Suppes Gift Fund, Stanford University.
  • I have an appointment as an Adjunct Associate Professor at the School of Public Health and Information Sciences, University of Louisville, Kentucky.  

Tom McBride

Associate Editor
0000-0003-3761-7672

Tom joined PLOS Medicine as an Associate Editor in April 2014, and has a strong interest in open access publishing, science communication, and global health. He received his undergraduate degree in Biology from the Massachusetts Institute of Technology in 2000, before joining Hypnion, a biotechnology company in Worcester, Massachusetts. At Hypnion, Tom was involved in genomics research and drug development for sleep therapeutics. He then moved to California, where he joined the Neuroscience Graduate Program at the University of California Davis. There, he studied micro-structural changes in neural circuitry that occur during learning, and received a PhD in Neuroscience in 2011. Following his graduate degree, Tom began postdoctoral research at the Buck Institute for Research on Aging, where he studied mouse models of Alzheimer’s disease.

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium. No.
  • Accommodation and travel. No.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

My wife is a researcher at Stanford University.

Stocks or shares

I hold several retirement accounts including a variety of mutual funds. I do not determine or keep track of the individual companies in which they invest.

Other competing interests 

  • I personally know authors who might submit research to PLOS Medicine.
  • I have donated money to the Sierra Club, the ACLU, and the ASPCA.

Linda Nevin

Associate Editor
0000-0003-4095-8574

Linda joined PLOS Medicine in July 2014, following a stint as a freelance editor for the journal. Previously she worked as a professional grantwriter and constructive editor with Science Editors Network (SEN), mainly for clients at the Stanford University School of Medicine. She earned her BS and MS degrees from Stanford and her PhD in Neuroscience from University of California San Francisco.

Competing Interests

Monetary or in kind compensation for self or household member from an organization that may in any way gain or lose financially or in any other way from the publication of papers in PLOS Medicine

  • Reimbursement for attending a conference or symposium. No.
  • Accommodation and travel. No.
  • Fees for speaking. No.
  • Fees for organizing education. No.
  • Funds for research or for a member of staff. No.
  • Fees for consulting. No.

Employment of self or household member by an organization that may in any way gain or lose financially from the publication of papers in PLOS Medicine

My husband is an investment analyst covering the pharmaceutical industry for his employer, The Capital Group Companies. 

Stocks or shares

My husband and I both hold mutual fund and retirement fund investments, but do not influence stock choices within those funds.

Other competing interests

I personally know authors who might submit research to PLOS Medicine.